76 results
F-1/A
AEZS
Aeterna Zentaris Inc.
29 Apr 24
Registration statement (foreign) (amended)
6:02pm
, both in connection with clinical activities and employees. The use of this information is critical to the Combined Company’s operations and innovation … market conditions in the biopharmaceutical sector. The Combined Company plans to prioritize agility, innovation, and adaptability to navigate
F-1
AEZS
Aeterna Zentaris Inc.
15 Feb 24
Registration statement (foreign)
4:54pm
of this information is critical to the Combined Company’s operations and innovation, including the development of the Combined Company’s products … , innovation, and adaptability to navigate the challenges and uncertainties inherent in the biopharmaceutical industry. The Combined Company also plans
6-K
EX-99.1
AEZS
Aeterna Zentaris Inc.
9 Apr 21
Annual Meeting of Shareholders
5:23pm
financial consulting and consultation in business through his own firm, Financium Inc. Prior to that he was Venture Partner of the NEOMED Innovation … Officer of the NEOMED Innovation Center, a division of the NEOMED Institute, and Chief Financial Officer of the NEOMED Institute since its inception
40-F
EX-99.1
2e6 7231frbfviokg
25 Mar 21
Annual report (Canada)
12:00am
20-F/A
EX-2.2
pd8 u5wdpr8
18 Jun 20
Annual report (foreign) (amended)
4:10pm
6-K
EX-99.1
tqh ul47jr3dgrn
21 Apr 20
Annual Meeting of Shareholders
12:00am
424B5
vjyyf35ak scst6c
21 Feb 20
Prospectus supplement for primary offering
9:33am
6-K
EX-99.1
8dzp9 6yw8h
16 Dec 19
Aeterna Zentaris Announces 2020 Director Changes
9:00am
424B5
ggkukloyuyirr9uo0
20 Sep 19
Prospectus supplement for primary offering
4:37pm
6-K
EX-3
wp9cobaplpw
1 Apr 19
Current report (foreign)
12:00am
6-K
EX-99.1
1etmywt
8 May 18
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
4:19pm
6-K
EX-99.1
sl1el6jjk
9 Apr 18
Annual and Special Meeting of Shareholders
12:00am